AGTC News and Press, Applied Genetic Technologies Corporation From 04/26/21

GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 26, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announc...

Applied Genetic Technologies ([[AGTC]] -5.3%) announces a licensing agreement to provide its proprietary cone specific promoter technology to genomic medicine company SparingVision SAS.Under the terms of the agreement, SparingVision SAS receives non-exclusive rights to AGTC’s...

-Technology To Be Incorporated In Multiple SparingVision SAS Programs- ALACHUA, Fla. and CAMBRIDGE, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associa...

Applied Genetic Technologies ([[AGTC]] -0.6%) and gene therapy company TeamedOn International have signed a licensing agreement to advance gene therapy to treat X-linked retinoschisis ((XLRS)), an inherited disease that causes loss of vision due to degeneration of the retina in males.Under th...

- AGTC Transfers Clinical Trial Materials and Phase 1/2 Data To TeamedON - ROCKVILLE, Md., April 13, 2021 (GLOBE NEWSWIRE) -- TeamedOn International, Inc., a biotechnology company dedicated to advancing gene therapies for rare diseases, including ophthalmic indications, and Applied ...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announc...

-AGTC’s deep commitment to the patient voice drives solutions to support patient access to information and to improve the experience of patients participating in clinical trials- GAINESVILLE, Fla., and CAMBRIDGE, Mass., March 25, 2021 (GLOBE NEWSWIRE) -- Applied Genetics Tech...

-AGTC will highlight the value of the patient voice in gene therapy development- GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-as...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announc...

Gainers: Luokung Technology (LKCO) +112%.Kubient (KBNT) +63%.SOS (SOS) +58%.Torchlight Energy Resources (TRCH) +54%.Protective Insurance (PTVCB) +53%.500.com (WBAI) +45%.ALJ Regional (ALJJ) +45%.Urban Tea (MYT) +44%.Canaan (CAN) +36%.Applied Genetic Technologies (AGTC) +32...